Engineered antibodies to human IL-23p19 are provided, as well as uses thereof, e.g. in treatment of inflammatory, autoimmune, and proliferative disorders.
申请公布号
EP1931710(B1)
申请公布日期
2017.01.18
申请号
EP20060802592
申请日期
2006.08.29
申请人
Merck Sharp & Dohme Corp.
发明人
PRESTA, Leonard, G.;ORTH, Peter;BEYER, Brian, M.;LIU, Yan-Hui;INGRAM, Richard, N.